Literature DB >> 15263100

Effect of ceasing creatine supplementation while maintaining resistance training in older men.

Darren G Candow1, Phillip D Chilibeck, Karen E Chad, Murray J Chrusch, K Shawn Davison, Darren G Burke.   

Abstract

The authors previously found that creatine (Cr) combined with 12 weeks of resistance training enhanced muscle strength and endurance and lean tissue mass (LTM) in older men. Their purpose in this study was to assess these variables with cessation of Cr combined with 12 weeks of reduced training (33% lower volume) in a subgroup of these men (n = 8, 73 years old) compared with 5 men (69 years old) who did not receive Cr. Strength (1-repetition maximum [1-RM]), endurance (maximum number of repetitions over 3 sets at 70-80% 1-RM), and LTM (dual-energy X-ray absorptiometry) were assessed before and after 12 weeks of Cr cessation combined with reduced-volume training. No changes in strength or LTM occurred. Muscle endurance was significantly reduced (7-21%; p <.05), with the rate of change similar between groups. Withdrawal from Cr had no effect on the rate of strength, endurance, and loss of lean tissue mass with 12 weeks of reduced-volume training. Copyright 2004 Human Kinetics Publishers, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15263100     DOI: 10.1123/japa.12.3.219

Source DB:  PubMed          Journal:  J Aging Phys Act        ISSN: 1063-8652            Impact factor:   1.961


  10 in total

Review 1.  Creatine Supplementation and Lower Limb Strength Performance: A Systematic Review and Meta-Analyses.

Authors:  Charlotte Lanhers; Bruno Pereira; Geraldine Naughton; Marion Trousselard; François-Xavier Lesage; Frédéric Dutheil
Journal:  Sports Med       Date:  2015-09       Impact factor: 11.136

2.  Current nutritional recommendations and novel dietary strategies to manage sarcopenia.

Authors:  Riccardo Calvani; Alfredo Miccheli; Francesco Landi; Maurizio Bossola; Matteo Cesari; Christiaan Leeuwenburgh; Cornel C Sieber; Roberto Bernabei; Emanuele Marzetti
Journal:  J Frailty Aging       Date:  2013

Review 3.  Optimal management of sarcopenia.

Authors:  Louise A Burton; Deepa Sumukadas
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

Review 4.  Progressive resistance strength training for improving physical function in older adults.

Authors:  Chiung-Ju Liu; Nancy K Latham
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

5.  Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.

Authors:  Richard Kones
Journal:  Clin Pharmacol       Date:  2010-09-17

Review 6.  Efficacy of Nutritional Interventions as Stand-Alone or Synergistic Treatments with Exercise for the Management of Sarcopenia.

Authors:  Sarah Damanti; Domenico Azzolino; Carlotta Roncaglione; Beatrice Arosio; Paolo Rossi; Matteo Cesari
Journal:  Nutrients       Date:  2019-08-23       Impact factor: 5.717

Review 7.  Current Evidence and Possible Future Applications of Creatine Supplementation for Older Adults.

Authors:  Darren G Candow; Scott C Forbes; Ben Kirk; Gustavo Duque
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

8.  The effects of age on skeletal muscle and the phosphocreatine energy system: can creatine supplementation help older adults.

Authors:  Vincent J Dalbo; Michael D Roberts; Chris M Lockwood; Patrick S Tucker; Richard B Kreider; Chad M Kerksick
Journal:  Dyn Med       Date:  2009-12-24

Review 9.  Creatine for Exercise and Sports Performance, with Recovery Considerations for Healthy Populations.

Authors:  Benjamin Wax; Chad M Kerksick; Andrew R Jagim; Jerry J Mayo; Brian C Lyons; Richard B Kreider
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

10.  International Society of Sports Nutrition position stand: creatine supplementation and exercise.

Authors:  Thomas W Buford; Richard B Kreider; Jeffrey R Stout; Mike Greenwood; Bill Campbell; Marie Spano; Tim Ziegenfuss; Hector Lopez; Jamie Landis; Jose Antonio
Journal:  J Int Soc Sports Nutr       Date:  2007-08-30       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.